Medistim ASA (OSL:MEDI)

Medistim ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	628.08	556.16	521.11	486.26	417.82	356.21
Revenue Growth (YoY)	17.80%	6.73%	7.17%	16.38%	17.30%	-0.20%
Cost of Revenue	120.95	113.68	112.28	106.49	97.11	76.58
Gross Profit	507.14	442.48	408.83	379.78	320.7	279.63
Selling, General & Admin	192.54	174.35	150.2	136.51	124.02	108.39
Other Operating Expenses	119.87	112.55	103.53	78.73	62.27	52.61
Operating Expenses	336.08	311.41	277.39	238.53	209.72	184.15
Operating Income	171.06	131.08	131.44	141.25	110.99	95.48
Interest Expense	-	-	-	-0.12	-0.18	-0.15
Interest & Investment Income	5.68	4.57	3.28	0.92	0.02	0.01
Currency Exchange Gain (Loss)	-1.88	-1.63	0.93	3.06	-1.81	-3.48
Other Non Operating Income (Expenses)	-2.88	0.23	-0.44	0.94	-0.24	-0.26
EBT Excluding Unusual Items	171.98	134.25	135.21	146.05	108.78	91.61
Other Unusual Items	-	-	-	-	5.29	-
Pretax Income	171.98	134.25	135.21	146.05	114.07	91.61
Income Tax Expense	40.84	30.41	31.39	32.08	23.17	22.22
Net Income	131.14	103.83	103.82	113.97	90.9	69.39
Net Income to Common	131.14	103.83	103.82	113.97	90.9	69.39
Net Income Growth	25.68%	0.01%	-8.91%	25.38%	31.00%	-1.31%
Shares Outstanding (Basic)	18	18	18	18	18	18
Shares Outstanding (Diluted)	18	18	18	18	18	18
Shares Change (YoY)	-0.07%	0.10%	0.10%	0.15%	0.07%	0.13%
EPS (Basic)	7.17	5.67	5.68	6.25	4.99	3.81
EPS (Diluted)	7.17	5.67	5.67	6.24	4.98	3.80
EPS Growth	25.74%	-0.01%	-9.13%	25.30%	31.05%	-1.55%
Free Cash Flow	146.12	137.04	102.8	104.24	119.97	66.68
Free Cash Flow Per Share	7.99	7.48	5.62	5.70	6.57	3.66
Dividend Per Share	6.000	6.000	4.500	4.500	3.750	3.000
Dividend Growth	33.33%	33.33%	-	20.00%	25.00%	9.09%
Gross Margin	80.74%	79.56%	78.45%	78.10%	76.76%	78.50%
Operating Margin	27.23%	23.57%	25.22%	29.05%	26.56%	26.81%
Profit Margin	20.88%	18.67%	19.92%	23.44%	21.76%	19.48%
Free Cash Flow Margin	23.27%	24.64%	19.73%	21.44%	28.71%	18.72%
EBITDA	184.78	146.8	146.72	157.45	127.26	105.06
EBITDA Margin	29.42%	26.39%	28.16%	32.38%	30.46%	29.49%
D&A For EBITDA	13.73	15.72	15.27	16.2	16.27	9.57
EBIT	171.06	131.08	131.44	141.25	110.99	95.48
EBIT Margin	27.23%	23.57%	25.22%	29.05%	26.56%	26.81%
Effective Tax Rate	23.75%	22.66%	23.21%	21.96%	20.31%	24.25%
Revenue as Reported	562.6	562.6	526.36	491.94	427.28	363.13

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.